ABS194
磷酸化PDHE1-A I型（Ser300）抗体
from rabbit, purified by affinity chromatography
别名:
Pyruvate dehydrogenase E1 component subunit alpha, somatic form, mitochondrial, PDHE1-A type I
产品名称
磷酸化PDHE1-A I型（Ser300）抗体, from rabbit, purified by affinity chromatography
biological source
rabbit
antibody form
affinity isolated antibody
antibody product type
primary antibodies
clone
polyclonal
purified by
affinity chromatography
species reactivity
human
species reactivity (predicted by homology)
mouse (based on 100% sequence homology), rat (based on 100% sequence homology), bovine (based on 100% sequence homology), Xenopus (based on 100% sequence homology), zebrafish (based on 100% sequence homology)
technique(s)
immunocytochemistry: suitable
western blot: suitable
NCBI accession no.
UniProt accession no.
shipped in
wet ice
target post-translational modification
phosphorylation (pSer300)
Quality Level
Gene Information
human ... PDHA1(5160)
Analysis Note
对照
二氯乙酸未处理和已处理的HEK 293细胞裂解液
二氯乙酸未处理和已处理的HEK 293细胞裂解液
已通过蛋白质印迹在二氯乙酸未处理和已处理的NIH/3T3细胞裂解液中进行了评估。
蛋白质印迹分析：0.5 µg/mL该抗体在10 µg二氯乙酸未处理和已处理的HEK 293细胞裂解液中检测到PDHE1-A 1型。
蛋白质印迹分析：0.5 µg/mL该抗体在10 µg二氯乙酸未处理和已处理的HEK 293细胞裂解液中检测到PDHE1-A 1型。
Application
免疫细胞化学分析： 代表性批次的1:500稀释液在二氯乙酸未处理和已处理的HEK 293细胞中检测到PDHE1-A 1型。
该抗磷酸化PDHE1-A 1型（Ser300）抗体经验证可用于在WB、IC中检测磷酸化PDHE1-A 1型（Ser300）。
Biochem/physiol Actions
该抗体可识别在Ser300磷酸化的PDHE1-A 1型。
General description
在许多生物体中，丙酮酸脱氢酶复合体除了作为心脏底物选择的关键调节因子外，还在有氧能量生成途径中催化丙酮酸到乙酰辅酶a和二氧化碳的总体不可逆转化。它含有三种酶成分的多个副本：丙酮酸脱氢酶（E1）、二氢脂酰胺乙酰转移酶（E2）和脂酰胺脱氢酶（E3）。PDH通过丙酮酸脱氢酶激酶（PDK）介导的磷酸化和反馈抑制调节。
观测值〜43 kDa
Immunogen
对应于在Ser300磷酸化的1型人PDHE1-A的KLH偶联线性肽。
表位：磷酸化Ser300
Other Notes
未找到合适的产品？
试试我们的产品选型工具.
存储类别
12 - Non Combustible Liquids
wgk
WGK 1
flash_point_f
Not applicable
flash_point_c
Not applicable
Yuan Z Feng et al.
Journal of lipid research, 58(11), 2147-2161 (2017-08-22)
Lipid droplet (LD) coating proteins are essential for the formation and stability of intracellular LDs. Plin2 is an abundant LD coating protein in skeletal muscle, but its importance for muscle function is unclear. We show that myotubes established from Plin2-/-
Jinxin Liu et al.
Theranostics, 11(17), 8283-8300 (2021-08-11)
Rationale: The molecular mechanisms underlying the pathogenesis of systemic insulin resistance in type 2 diabetes remain elusive. Growth hormone receptor (GHR) deficiency has long been known to improved insulin sensitivity. However, whether hepatic GHR overexpression or activation is a cause
PP2A-based triple-strike therapy overcomes mitochondrial apoptosis resistance in brain cancer cells.
Oxana V Denisova et al.
Molecular oncology, 17(9), 1803-1820 (2023-07-17)
Mitochondrial glycolysis and hyperactivity of the phosphatidylinositol 3-kinase-protein kinase B (AKT) pathway are hallmarks of malignant brain tumors. However, kinase inhibitors targeting AKT (AKTi) or the glycolysis master regulator pyruvate dehydrogenase kinase (PDKi) have failed to provide clinical benefits for
Kenichi Aizawa et al.
Cells, 13(1) (2024-01-11)
Heart failure with reduced ejection fraction (HFrEF) is characterized not only by reduced left ventricular ejection fraction (EF) but is also combined with symptoms such as dyspnea, fatigue, and edema. Several pharmacological interventions have been established. However, a treatment targeting
G Perez-Siles et al.
Scientific reports, 10(1), 9262-9262 (2020-06-07)
Charcot-Marie-Tooth (CMT) is a group of inherited diseases clinically and genetically heterogenous, characterised by length dependent degeneration of axons of the peripheral nervous system. A missense mutation (p.R158H) in the pyruvate dehydrogenase kinase 3 gene (PDK3) has been identified as
我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.
联系客户支持